Lyric Bio
Next Generation Biomanufacturing
San Francisco, United States · $6.6M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- lyricbio.com
- Total Funding
- $6.6M
- Last Round
- $6.6M SeedDec 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Lyric Bio is building next-generation biomanufacturing platforms for human donor-sourced therapeutics.
Summary
Lyric Bio is a Biotech company based in San Francisco, United States. It has raised $6.6M in total across 1 round, most recently a $6.6M Seed round in Dec 2025. Investors include The Venture Collective, Black Diamond Ventures and Draper Associates.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lyric-bio"><img src="https://indexed.vc/api/badge/company/lyric-bio" alt="Lyric Bio on Indexed.vc" width="260" height="76" /></a>